Keyphrases
Doxorubicin
100%
Senolytics
100%
Human Umbilical Vein
100%
Senescence Phenotype
100%
ABT-263
100%
Expression Level
28%
Bcl-2 Family Proteins
28%
Induced Senescence
28%
Differential Expression
14%
Endothelial Dysfunction
14%
Apoptosis
14%
Senescent Cells
14%
Dasatinib
14%
Senescence
14%
Fisetin
14%
Senescence Markers
14%
Cell Cycle Arrest
14%
Human Umbilical Vein Endothelial Cells (HUVECs)
14%
Quercetin
14%
Cardiovascular Complications
14%
Primary Endothelial Cells
14%
Senescence-associated Secretory Phenotype
14%
Endothelial Senescence
14%
Navitoclax
14%
Doxorubicin Treatments
14%
Medicine and Dentistry
Umbilical Vein
100%
Doxorubicin
100%
Endothelial Cell
25%
Protein Family
25%
Endothelial Dysfunction
12%
Programmed Cell Death
12%
Cardiovascular Disease
12%
Cell Cycle Arrest
12%
Human Umbilical Vein Endothelial Cell
12%
Galactose
12%
Cell Cycle Checkpoint
12%
Quercetin
12%
Cellular Senescence
12%
Fisetin
12%
Navitoclax
12%
Dasatinib
12%